Sign up USA
Proactive Investors - Run By Investors For Investors

Canadian medical marijuana company MPX Bioceutical uplists to OTCQX exchange

CEO W Scott Boyes said the move would improve liquidity in the company’s stock and drive shareholder value
MPX Bioceutical's Health Health for Life outlet in Arizona
The Canadian medical marijuana company has a growing presence in the US

MPX Bioceutical Corp (CSE:MPX, OTCMKTS:MPXEF) announced Wednesday that shares of the Canadian medical marijuana company have moved to the OTCQX market.

Stocks that trade on the OTCQX meet more stringent qualification criteria compared to other over-the-counter stocks that trade in the OTCQB Venture and more speculative Pink Sheets.  

“Over the past year MPX experienced significant operational changes and reached many corporate milestones, growing its Arizona footprint, acquiring cultivation, production and kitchen facilities in Nevada, opening its first cannabis dispensary in Maryland and expanding into Canada,” MPX Bioceutical CEO W Scott Boyes said in a statement.

Boyes said that upgrading to the OTCQX from the OTCQB demonstrates the cannabis grower’s commitment to “transparency, professionalism and integrity.”

“It is an important step toward improving liquidity in our stock as we continue to drive shareholder value,” said Boyes.

READ: Aurora Cannabis files to list on NYSE in search of institutional investors

The Toronto-based medical marijuana company has a growing presence in the US with plans for ten dispensaries and four production facilities in four states. It already has profitable operations in Arizona where it has three fully operational Health for Life and a fourth Holistic Center dispensary.

MPX Bioceutical has a joint venture agreement with Panaxia to develop proprietary, smokeless pharma-grade products using cannabis.

In Canada, MPX Bioceutical has acquired Canveda which has a cultivation license from Health Canada. The company has also leased a 74,343 square foot cultivation and production facility in Owen Sound, Ontario and applied to Health Canada for a cannabis production and sales license.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

Join our Crypto, Blockchain and Cannabis Telegram group here
View full MPX profile View Profile

MPX Bioceutical Corp Timeline

Related Articles

The biotech was founded by an investment group led by scientists and driven by a no-nonsense CEO whose stake is more than just business as usual
picture of cannabis plants
March 23 2018
Control of the supply chain offers operational advantages and financial benefits.
scientist in lab
August 31 2018
While the data bodes well for MTD201, Midatech is most excited by the validation of its Q-Sphera sustained release technology, which it is using in some of its other compounds

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright ©, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use